1 month ago
1
PULSE POINTS:
❓What Happened: Regeneron has agreed to purchase 23andMe for $256 million through a court-supervised bankruptcy sale.
👥 Who’s Involved: Regeneron Pharmaceuticals, 23andMe, Anne Wojcicki (former CEO), Joe Selsavage (interim CEO).
Your free, daily feed from The National Pulse.
📍 Where & When: The deal was announced Monday; 23andMe filed for bankruptcy in March 2025.
💬 Key Quote: “We are pleased to reach an agreement with a science-driven partner that maintains our team and helps ensure our mission will carry forward,” said Joe Selsavage, 23andMe’s interim CEO.
⚠️ Impact: Regeneron will acquire 23andMe’s genetic testing and research assets but not its telehealth business, while committing to uphold privacy laws and policies.
IN FULL:
Regeneron Pharmaceuticals has finalized a $256 million agreement to acquire genetic testing company 23andMe, following the latter’s bankruptcy filing earlier this year. The purchase, made under a court-supervised sale process, includes 23andMe’s genetic testing services and health research assets but excludes its Lemonaid Health telehealth division.
Notably, President Donald J. Trump received a dose of a Regeneron antibody drug in late 2020 when he was diagnosed with COVID-19. At the time, the medication was still in an experimental phase, but showed promise as a treatment for the virus.
The consumer genetic testing company 23andMe filed for bankruptcy in March 2025, citing financial difficulties. At the time, it announced plans to seek a buyer and confirmed the resignation of its co-founder and CEO, Anne Wojcicki.
Under the terms of the agreement, Regeneron, based in Tarrytown, New York, will continue to provide 23andMe’s consumer genetic services without interruption. The company also emphasized its commitment to adhering to 23andMe’s existing privacy policies and applicable laws to safeguard sensitive customer information.
“We have deep experience with large-scale data management,” said George Yancopoulos, Regeneron’s co-founder, in a statement. He added: “With the consent of individuals, we use this data to drive discoveries that benefit science and society, while maintaining a strong track record of protecting genetic data.”
Privacy concerns have surrounded 23andMe’s vast database, which includes the DNA information of approximately 15 million customers. The company’s services allow users to explore their ancestry and genetic health profiles, including identifying potential hereditary risks. Its research wing has also been involved in developing treatments for cancer, immune disorders, and other conditions.
Interim CEO Joe Selsavage expressed optimism about the acquisition, stating, “We are pleased to reach an agreement with a science-driven partner that maintains our team and helps ensure our mission will carry forward. With Regeneron’s expertise in genetic sequencing, testing, and discovery, we look forward to continuing to help people access and understand the human genome for the benefit of customers and patients.”
PULSE POINTS:
❓What Happened: President Donald J. Trump questioned whether Kamala Harris paid entertainment elites for endorsements during her 2024 campaign.
👥 Who’s Involved: President Trump, Kamala Harris, Bruce Springsteen, Beyoncé Knowles-Carter, Oprah Winfrey, Samuel L. Jackson, Spike Lee, and Tyler Perry.
Your free, daily feed from The National Pulse.
📍 Where & When: Trump made the statement on Truth Social on Monday, May 19, 2025; celebrity endorsements occurred during Harris’s 2024 campaign rallies in various locations, including Atlanta, Georgia, and Houston, Texas.
💬 Key Quote: “BRUCE SPRINGSTEEN, OPRAH, BONO AND, PERHAPS, MANY OTHERS, HAVE A LOT OF EXPLAINING TO DO!!!” — President Trump.
⚠️ Impact: Trump’s comments raise questions about potential election law violations and the role of celebrity influence in political campaigns.
IN FULL:
President Donald J. Trump has raised concerns over whether Kamala Harris compensated entertainment elites for their endorsements during her struggling 2024 presidential campaign. In a post on Truth Social on Monday morning, Trump raised the possibility, suggesting a potential investigation into whether election laws were violated.
“According to news reports, Beyoncé was paid $11,000,000 to walk onto a stage, quickly ENDORSE KAMALA, and walk off to loud booing for never having performed, NOT EVEN ONE SONG!” Trump wrote, continuing: “Remember, the Democrats and Kamala illegally paid her millions of Dollars for doing nothing other than giving Kamala a full throated ENDORSEMENT.”
He added: “THIS IS AN ILLEGAL ELECTION SCAM AT THE HIGHEST LEVEL! IT IS AN ILLEGAL CAMPAIGN CONTRIBUTION! BRUCE SPRINGSTEEN, OPRAH, BONO AND, PERHAPS, MANY OTHERS, HAVE A LOT OF EXPLAINING TO DO!!!”
The President’s accusations come amid renewed attacks from Bruce Springsteen, who drew Trump’s ire last week. During the 2024 presidential campaign, Springsteen announced his support for Harris, stating, “Donald Trump is the most dangerous candidate for president in my lifetime.”
At a campaign rally in Atlanta, Georgia, Harris received backing from a host of Hollywood stars, including Samuel L. Jackson, Spike Lee, and Tyler Perry. Meanwhile, pop icon Beyoncé Knowles-Carter endorsed Harris during a rally in Houston, Texas, focusing her remarks on abortion.
“I’m not here as a celebrity, I’m not here as a politician. I’m here as a mother,” Beyoncé stated. “Imagine our daughters growing up seeing what’s possible with no ceilings, no limitations.”
Trump’s Truth Social post suggests he believes these endorsements may warrant scrutiny under election law. Notably, campaign finance records indicate that the Harris campaign paid at least $1 million to Oprah‘s production company. This payment was supposedly in exchange for the company’s assistance with the “United for America” livestream rally featuring numerous celebrities and endorsements in September 2024.
show less
English (US) ·